Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitermi.com.ru/en
Phone+7 495 545-39-12
Employees
Founded2012

Funds

Offices

RusnanoMedInvest
29 1st Brestskaya Street
Moscow, RUS

People

Managing Director

Tags

RusnanoMedInvest

RusnanoMedInvest (RMI) is Russia’s and Eastern Europe’s largest venture capital company specializing in innovative developments in the field of pharmaceuticals and biotechnology.

The RusnanoMedInvest fund was established by RUSNANO JSC, the nanotechnology investment, research and development arm of the Russian Government together with Domain Associates LLC, one of the premier U.S. life sciences technology venture investment firms. The RusnanoMedInvest fund seeks, in addition to securing differentiated and sustainable returns to its investment portfolio, to promote the following social and developmental objectives in Russia.

Recent Milestones

Investments

Company Date Round Size Participants
Miramar Labs 2/2014Series D$10M5
NovaDigm Therapeutics 10/2013Series B$14M2
Syndax Pharmaceuticals 8/2013Series B$26.6M4
ReVision Optics 7/2013Private Equity$55M6
Regado Biosciences 12/2012Series E$51M8

Videos

Sources

  1. Miramar Labs Raises $10M in Series D Funding (finsmes.com) [edit]
  2. NovaDigm Therapeutics Closes $14M Series B Financing (finsmes.com) [edit]
  3. Syndax Pharmaceuticals Secures $26.6M Series B Financing (finsmes.com) [edit]
  4. ReVision Optics Raises $55M In Equity Financing (finsmes.com) [edit]
  5. Regado Biosciences, Inc. Secures $51 Million Series E Financing (regadobio.investorroom.com) [edit]
Edit This Page
Last Edited 2/13/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy